Amphastar Pharmaceuticals (AMPH) Change in Cash (2016 - 2025)
Amphastar Pharmaceuticals has reported Change in Cash over the past 13 years, most recently at -$46.1 million for Q4 2025.
- Quarterly results put Change in Cash at -$46.1 million for Q4 2025, down 13.78% from a year ago — trailing twelve months through Dec 2025 was $18.6 million (up 153.9% YoY), and the annual figure for FY2025 was $18.6 million, up 153.9%.
- Change in Cash for Q4 2025 was -$46.1 million at Amphastar Pharmaceuticals, down from $28.6 million in the prior quarter.
- Over the last five years, Change in Cash for AMPH hit a ceiling of $119.8 million in Q3 2023 and a floor of -$126.5 million in Q4 2023.
- Median Change in Cash over the past 5 years was $3.7 million (2024), compared with a mean of $3.8 million.
- Peak annual rise in Change in Cash hit 1443.62% in 2023, while the deepest fall reached 10938.92% in 2023.
- Amphastar Pharmaceuticals' Change in Cash stood at $19.7 million in 2021, then crashed by 105.8% to -$1.1 million in 2022, then crashed by 10938.92% to -$126.5 million in 2023, then skyrocketed by 67.98% to -$40.5 million in 2024, then dropped by 13.78% to -$46.1 million in 2025.
- The last three reported values for Change in Cash were -$46.1 million (Q4 2025), $28.6 million (Q3 2025), and $4.9 million (Q2 2025) per Business Quant data.